Ligand Reports First Quarter 2025 Financial Results
May 8, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, …
Ligand Pharmaceuticals Incorporated - Stock Info
5 days ago · All 3m NASDAQ:LGND News Releases Sep 8 Sep 15 Sep 22 Sep 29 Oct 6 Oct 13 Oct 20 Oct 27 Nov 3 Nov 10 Nov 17 Nov 24 Dec 1 2020 2021 2022 2023 2024 2025 140 160 180 200 ...
Ligand Pharmaceuticals Incorporated - Investor Relations
Oct 30, 2025 · Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value …
Ligand Pharmaceuticals Incorporated - Ligand Reports Third Quarter …
Nov 6, 2025 · For more information, please visit www.ligand.com. Follow Ligand on X and LinkedIn. We use our investor relations website and X as a means of disclosing material non-public information …
Ligand Pharmaceuticals - Biopharma's Technology and Capital Partner
Ligand invests in the clinical development and commercialization of high-value medicines. We manage one of the largest and most diverse portfolios of biopharmaceutical royalties in the industry, with …
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel …
Apr 17, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, …
News & Events - Press Releases - Ligand Pharmaceuticals
Oct 16, 2025 · Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030 Download , Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes …
Ligand and Medtronic Commit $70 Million in Strategic Capital to ...
Jul 31, 2025 · Ligand’s decision to invest in our partnered programs and our team reflects our shared conviction in the transformative potential of both AVIM therapy and Virtue SAB—our late-stage …
Financials - Quarterly Results - Ligand Pharmaceuticals
Ligand does this by providing financing, licensing our technologies or both. Our business model seeks to generate value for stockholders by creating a diversified portfolio of biotech and pharmaceutical …
Ligand to Ring the Nasdaq Opening Bell on May 19, 2025
May 14, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, …